Research Repository

Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy

Tomek, Mary and Akiyama, Toru and Dass, Crispin R (2012) Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy. Journal of Pharmacy and Pharmacology, 64 (12). pp. 1695-1702. ISSN 0022-3573 (print) 2042-7158 (online)

Full text for this resource is not available from the Research Repository.

Abstract

Bcl-2 is a protein that inhibits apoptosis, leading to cell survival. The Bcl-2 family has six different anti-apoptotic proteins, three pro-apoptotic proteins that are similar in structure, and other integrating proteins that function as promotors or inhibitors in the progression of apoptosis. In this discussion paper, we provide an overview of apoptosis, the role of Bcl-2 in normal cellular and molecular processes, and the role of Bcl-2 in tumour cell survival. It focuses primarily on anti-apoptotic Bcl-2, its activation in cancer, the manner in which it regulates the intrinsic and extrinsic mechanisms of apoptosis, and its broad molecular interactions with other critical proteins in the cell. Certain cancer treatments are reviewed and related directions for the future are presented.

Item Type: Article
Uncontrolled Keywords: ResPubID25800, apoptosis, Bcl-2, cancer, cell survival, FKBP-38, Nur-77, tumour cells
Subjects: FOR Classification > 1112 Oncology and Carcinogenesis
FOR Classification > 1115 Pharmacology and Pharmaceutical Sciences
Faculty/School/Research Centre/Department > College of Health and Biomedicine
Depositing User: Yimin Zeng
Date Deposited: 22 Jul 2014 00:26
Last Modified: 12 Aug 2014 00:29
URI: http://vuir.vu.edu.au/id/eprint/23173
DOI: 10.1111/j.2042-7158.2012.01526.x
ePrint Statistics: View download statistics for this item

Repository staff only

View Item View Item

Search Google Scholar